Company / Return on Equity (ROE)
ABEONA THERAPEUTICS INC. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
44.7%
FY2025
5-year range
-365.5% / 44.7%
FY2021-FY2025
Trend
+112.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) has fluctuated over the past 10 years, ranging from -433.6% in FY2019 to 44.7% in FY2025.
Based on SEC 10-K filings.
44.7% in FY2025 with a 5-year CAGR of +87.5%.
Improved from -148.3% to 44.7% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +245.2pp
- 5-Year Change
- +87.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 112.2% year-over-year.
- Lowest return on equity (roe) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 44.7% | +112.2% |
| FY2024 | -365.5% | -146.4% |
| FY2023 | -148.3% | +26.0% |
| FY2022 | -200.5% | -144.1% |
| FY2021 | -82.1% | -92.1% |
| FY2020 | -42.8% | +90.1% |
| FY2019 | -433.6% | -925.6% |
| FY2018 | -42.3% | -163.3% |
| FY2017 | -16.1% | +25.1% |
| FY2016 | -21.4% | +96.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026